List of insiders holdings for RELMADA THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Wessel Thomas EVP, Head of R&D | 2020-03-16 17:41:25 | 350,000 0 | 350,000 | Form 3 |
Yazgi Nabil Director | 2015-01-16 16:25:51 | 204,912 75,000 | 279,912 | Form 3 |
Salinas Eliseo Oreste President and CSO | 2015-03-05 17:16:43 | 250,944 0 | 250,944 | Form 4 |
TRAVERSA SERGIO Chief Executive Officer | 2024-01-31 18:29:27 | 244,024 0 | 244,024 | Form 4 |
SCHMIDT ERIC THOMAS Director | 2023-05-30 17:09:03 | 150,000 0 | 150,000 | Form 4 |
SETH SANDESH Director | 2015-12-17 09:38:04 | 123,258 0 | 123,258 | Form 4 |
Vitolo Ottavio V. CMO | 2019-12-23 16:53:15 | 105,000 0 | 105,000 | Form 4 |
BECK DOUGLAS Chief Financial Officer | 2015-03-05 17:15:48 | 104,437 0 | 104,437 | Form 4 |
Kelly Paul Edward Director | 2023-12-19 17:28:09 | 65,672 0 | 65,672 | Form 4 |
Nolan Lisa Chief Business Officer | 2015-12-17 17:02:37 | 60,000 0 | 60,000 | Form 3 |
Ence Chuck CA and CO | 2024-01-31 18:28:02 | 38,970 0 | 38,970 | Form 4 |
Shenouda Maged Chief Financial Officer | 2024-01-31 18:28:58 | 34,903 0 | 34,903 | Form 4 |
CASAMENTO CHARLES J Director | 2023-12-19 17:26:46 | 31,522 0 | 31,522 | Form 4 |
Fedeli Fabiana Director | 2023-12-19 17:27:35 | 31,522 0 | 31,522 | Form 4 |
GLASSPOOL JOHN Director | 2023-12-19 17:27:59 | 31,522 0 | 31,522 | Form 4 |
O'Gorman Cedric Chief Medical Officer | 2023-05-24 09:00:22 | 10,121 0 | 10,121 | Form 4 |
Agharkar Shreeram Director | 2016-01-05 16:35:00 | 5759 0 | 5759 | Form 4 |